SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-15-006928
Filing Date
2015-09-11
Accepted
2015-09-11 16:55:16
Documents
12
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2015_relmada.htm 10-K 1408300
2 LIST OF SUBSIDIARIES f10k2015ex21i_relmada.htm EX-21.1 792
3 CERTIFICATION f10k2015ex31i_relmada.htm EX-31.1 8044
4 CERTIFICATION f10k2015ex31ii_relmada.htm EX-31.2 7721
5 CERTIFICATION f10k2015ex32i_relmada.htm EX-32.1 3761
6 CERTIFICATION f10k2015ex32ii_relmada.htm EX-32.2 4241
  Complete submission text file 0001213900-15-006928.txt   6896501

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE relm-20150630.xml EX-101.INS 1403201
8 XBRL SCHEMA FILE relm-20150630.xsd EX-101.SCH 62085
9 XBRL CALCULATION FILE relm-20150630_cal.xml EX-101.CAL 35149
10 XBRL DEFINITION FILE relm-20150630_def.xml EX-101.DEF 290336
11 XBRL LABEL FILE relm-20150630_lab.xml EX-101.LAB 525095
12 XBRL PRESENTATION FILE relm-20150630_pre.xml EX-101.PRE 415852
Mailing Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-702-7163
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-55347 | Film No.: 151103786
SIC: 2834 Pharmaceutical Preparations